c6 peptide elisa can be used to diagnose Lyme disease - c-peptide-valori Single-tier testing with the C6 peptide ELISA kit

c5a-peptide The C6 peptide ELISA is a crucial diagnostic tool for identifying Lyme disease, particularly in individuals who may have received the OspA vaccine.作者：PJ Molloy·2018·被引用次数：50—The purpose of this study was to evaluate whether theFDA-approved C6 peptide enzyme-linked immunosorbent assay (ELISA) currently used to diagnose Lyme disease ... This immunoassay utilizes a synthetic peptide derived from the VlsE surface protein of *Borrelia*, the bacterium responsible for Lyme disease. The C6 peptide is highly antigenically reactive, meaning it elicits a strong immune response that can be reliably detected. This test is designed to detect both IgG and IgM antibodies against the C6 peptide, offering a comprehensive approach to serodiagnosis.

Understanding the C6 Peptide in Lyme Disease Diagnosis

The C6 peptide itself is a specific segment of the VlsE protein, a variable surface antigen expressed by *Borrelia burgdorferi*. The development of an ELISA that targets antibodies against this particular peptide has significantly advanced the accuracy of Lyme disease diagnosticsHuman C6 ELISA Kit. Unlike some older methods, the C6 peptide ELISA has demonstrated high sensitivity and specificity, even in early stages of the disease作者：GP Wormser·2013·被引用次数：189—The C6 ELISA as a single-step serodiagnostic test providedincreased sensitivity in early Lyme diseasewith comparable sensitivity in later manifestations of .... Its performance evaluation has frequently been compared to established two-tier testing algorithms, with many studies indicating that the C6 ELISA can offer increased sensitivity, especially in early Lyme disease presentations.

One of the key advantages of the C6 peptide ELISA is its ability to distinguish between antibodies generated from natural infection and those resulting from vaccination. Antibodies to the C6 peptide are generally indicative of natural infection, whereas antibodies induced by the OspA vaccine do not typically react with this peptide.Single-tier testing with the C6 peptide ELISA kit compared ... This distinction is vital for accurate diagnosis, especially in endemic areas where vaccination might be employedBorrelia Vmp-like sequence expressed (VlsE) C6 peptide-Biotin (>90%) for ELISA. Availability, In Stock. Product Type, Antibody Blocking Peptide.. Furthermore, research suggests that the C6 peptide test may also show promise in identifying infections with other *Borrelia* species, such as *Borrelia miyamotoi*Evaluation of the C6 Peptide Enzyme-Linked Immunosorbent ....

Applications and Performance of the C6 Peptide ELISA

The C6 peptide ELISA has been extensively studied and evaluated for its diagnostic utility in various scenarios.作者：I Tjernberg·2007·被引用次数：68—Overall, a positive C6 test seems tocorrelate well with acute borreliosis. Cross-reactivity was lower in the C6 test in sera positive for ... Studies have explored its use as a first-line test in a tiered serological scheme for *Borrelia* detection, and its performance has been assessed across multiple laboratories. The test's ability to correlate well with acute borreliosis has been consistently reported, with lower rates of cross-reactivity observed when compared to other serological methods, even in sera positive for other infections like Epstein-Barr virus.Borrelia Vmp-like sequence expressed (VlsE) C6 peptide-Biotin (>90%) for ELISA. Availability, In Stock. Product Type, Antibody Blocking Peptide.

The sensitivity and specificity of the C6-peptide ELISA have also been investigated in different sample types, including cerebrospinal fluid for neuroborreliosis patients. This highlights the versatility of the assay. The underlying principle of the C6 ELISA is based on antibody-antigen interactions, where the presence of specific antibodies in a patient's serum binds to the immobilized C6 peptide on the assay plate.VlsE C6 peptide and IgG ELISA antibody analysis for ... This binding is then detected through a series of enzymatic reactions, ultimately producing a measurable signal.

C6 Peptide ELISA Kits and Future Directions

Various C6 Lyme ELISA kits are available, with manufacturers often emphasizing their accuracy and reliability作者：AR Marques·2002·被引用次数：49—The C6 peptide ELISAcan be used to diagnose Lyme diseasein patients who have received the OspA vaccine.. For instance, kits based on the C6 peptide of the VlsE protein are marketed as a significant advancement in diagnostic accuracy. These kits are designed for the detection of both IgG and IgM antibodies, ensuring broad coverage for different stages of infectionSingle-tier testing with the C6 peptide ELISA kit compared .... The development of such kits has streamlined the diagnostic process, allowing for more efficient and accurate identification of Lyme disease.

While the primary application of the C6 peptide ELISA is for Lyme disease, ongoing research continues to explore its potential in broader contexts. The detection of antibodies against C6 peptides using ELISA has shown promising sensitivity for detecting Lyme diseaseC6 Lyme Elisa - Laboratory tests in Europe. As research progresses, the C6 peptide ELISA remains a cornerstone in the serodiagnosis of Lyme borreliosis, offering a sensitive and specific method for identifying infection and aiding in timely clinical management.